A 12-week study from Texas A&M University found that creatine supplementation helped middle-aged adults (45–65) gain lean muscle and strength even without structured exercise, with greater benefits when combined with resistance training and calorie restriction. The results suggest creatine may be a useful tool for preserving muscle mass and supporting healthy aging.
Japan's population fell 2.5% to 122.9 million between 2020 and 2025, marking the third consecutive five-year decline. Japanese nationals decreased 3.5% while foreign residents surged 39.8%, with Chinese nationals comprising the largest share. The aging population continued rising, with those 65 and older reaching 29.4%, while Tokyo remained the only prefecture with growth.
The article discusses how transplanted organs may biologically adjust to match their recipient's age rather than retaining their donor's age, but the full content failed to load due to technical issues.
A Penn State study of 232 adults in their 40s found that rapid biological aging during midlife predicts prospective memory lapses (forgetting planned tasks) a decade later, with faster agers 18 percent more likely to experience these lapses. The research suggests monitoring cognitive changes early could help prevent dementia and improve long-term quality of life.
New research on heart transplants in mice and humans suggests that transplanted young organs quickly adopt the biological age of the recipient, contradicting theories that young organs could rejuvenate aging bodies. Scientists used molecular aging clocks to track transplanted hearts and found they aged or rejuvenated to match their recipients' biological age, indicating that the recipient's internal environment, rather than the donor organ's youth, determines the organ's aging trajectory.
Researchers at the University of Missouri discovered that age-related muscle weakness in older adults results from deteriorating communication between nerves and muscles at the neuromuscular junction, caused by reduced levels of the NaV1.4 protein. They identified a potential treatment by targeting the ClC-1 protein, which in animal models improved muscle strength and responsiveness to nerve signals, offering a potentially reversible approach to sarcopenia affecting nearly half of adults over 80.
Scientists at the University of Missouri discovered that age-related muscle weakness stems from deteriorating communication between nerves and muscles, specifically involving reduced levels of the protein NaV1.4. Researchers demonstrated that partially inhibiting a protein called ClC-1 improved muscle responsiveness to nerve signals in animal models, offering a potential therapeutic path to treat sarcopenia and preserve strength in older adults.